BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 20427748)

  • 1. All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.
    Labussière M; Idbaih A; Wang XW; Marie Y; Boisselier B; Falet C; Paris S; Laffaire J; Carpentier C; Crinière E; Ducray F; El Hallani S; Mokhtari K; Hoang-Xuan K; Delattre JY; Sanson M
    Neurology; 2010 Jun; 74(23):1886-90. PubMed ID: 20427748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience.
    Frenel JS; Leux C; Loussouarn D; Le Loupp AG; Leclair F; Aumont M; Mervoyer A; Martin S; Denis MG; Campone M
    J Neurooncol; 2013 Aug; 114(1):85-91. PubMed ID: 23681562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of isocitrate dehydrogenase 1, O6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients.
    Takahashi Y; Nakamura H; Makino K; Hide T; Muta D; Kamada H; Kuratsu J
    World J Surg Oncol; 2013 Oct; 11():284. PubMed ID: 24160898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH mutations: genotype-phenotype correlation and prognostic impact.
    Wang XW; Ciccarino P; Rossetto M; Boisselier B; Marie Y; Desestret V; Gleize V; Mokhtari K; Sanson M; Labussière M
    Biomed Res Int; 2014; 2014():540236. PubMed ID: 24877111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system.
    Figarella-Branger D; Bouvier C; de Paula AM; Mokhtari K; Colin C; Loundou A; Chinot O; Metellus P
    J Neurooncol; 2012 Nov; 110(2):205-13. PubMed ID: 22890969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas.
    Wang LM; Li Z; Piao YS; Cai YN; Zhang LY; Ge HJ; Xu WW; Lu DH
    Chin Med J (Engl); 2019 Dec; 132(24):2920-2926. PubMed ID: 31833906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.
    Houillier C; Wang X; Kaloshi G; Mokhtari K; Guillevin R; Laffaire J; Paris S; Boisselier B; Idbaih A; Laigle-Donadey F; Hoang-Xuan K; Sanson M; Delattre JY
    Neurology; 2010 Oct; 75(17):1560-6. PubMed ID: 20975057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH.
    de Biase D; Acquaviva G; Visani M; Marucci G; De Leo A; Maloberti T; Sanza V; Di Oto E; Franceschi E; Mura A; Ragazzi M; Serra S; Froio E; Bisagni A; Brandes AA; Pession A; Tallini G
    J Mol Diagn; 2021 Sep; 23(9):1185-1194. PubMed ID: 34186176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of
    Park YW; Han K; Ahn SS; Bae S; Choi YS; Chang JH; Kim SH; Kang SG; Lee SK
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):37-42. PubMed ID: 29122763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.
    Ducray F; Mokhtari K; Crinière E; Idbaih A; Marie Y; Dehais C; Paris S; Carpentier C; Dieme MJ; Adam C; Hoang-Xuan K; Duyckaerts C; Delattre JY; Sanson M
    Eur J Cancer; 2011 Mar; 47(5):802-8. PubMed ID: 21194923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of glioma and IDH1/IDH2 mutations.
    Rossetto M; Ciccarino P; Boisselier B; Labussiere M; Sanson M
    Rev Neurol (Paris); 2011 Oct; 167(10):699-703. PubMed ID: 21885076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    Garton ALA; Kinslow CJ; Rae AI; Mehta A; Pannullo SC; Magge RS; Ramakrishna R; McKhann GM; Sisti MB; Bruce JN; Canoll P; Cheng SK; Sonabend AM; Wang TJC
    J Neurosurg; 2020 May; 134(5):1357-1367. PubMed ID: 32384274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?
    Kloosterhof NK; Bralten LB; Dubbink HJ; French PJ; van den Bent MJ
    Lancet Oncol; 2011 Jan; 12(1):83-91. PubMed ID: 20615753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
    Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis.
    Zhang ZY; Chan AK; Ng HK; Ding XJ; Li YX; Shi ZF; Zhu W; Zhong P; Wang Y; Mao Y; Yao Y; Zhou LF
    Int J Clin Exp Pathol; 2014; 7(12):8627-36. PubMed ID: 25674227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis.
    Phan K; Ng W; Lu VM; McDonald KL; Fairhall J; Reddy R; Wilson P
    World Neurosurg; 2018 Mar; 111():e539-e545. PubMed ID: 29288860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrosequencing of IDH1 and IDH2 mutations in brain tumors and non-neoplastic conditions.
    Cykowski MD; Allen RA; Fung KM; Harmon MA; Dunn ST
    Diagn Mol Pathol; 2012 Dec; 21(4):214-20. PubMed ID: 23111198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results.
    Ballester LY; Huse JT; Tang G; Fuller GN
    Hum Pathol; 2017 Nov; 69():15-22. PubMed ID: 28549927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of
    Park YW; Han K; Ahn SS; Choi YS; Chang JH; Kim SH; Kang SG; Kim EH; Lee SK
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):693-698. PubMed ID: 29519794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas.
    Gleize V; Alentorn A; Connen de Kérillis L; Labussière M; Nadaradjane AA; Mundwiller E; Ottolenghi C; Mangesius S; Rahimian A; Ducray F; ; Mokhtari K; Villa C; Sanson M
    Ann Neurol; 2015 Sep; 78(3):355-74. PubMed ID: 26017892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.